TRAVASOL
TRAVASOL
Approved
DIN Number
00872296
Drug Class
Human
Market Date
Dec 31, 1991
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00872296
AIG Number1517080002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (15)
ARGININEActive
Strength: 1.15 G / 100 ML
Monograph: ARGININE
GLYCINEActive
Strength: 1.03 G / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 480 MG / 100 ML
Monograph: HISTIDINE
ISOLEUCINEActive
Strength: 600 MG / 100 ML
Monograph: ISOLEUCINE
L-ALANINEActive
Strength: 2.07 G / 100 ML
Monograph: L-ALANINE
L-LYSINE (L-LYSINE HYDROCHLORIDE)Active
Strength: 580 MG / 100 ML
Monograph: L-LYSINE (L-LYSINE HYDROCHLORIDE)
LEUCINEActive
Strength: 730 MG / 100 ML
Monograph: LEUCINE
METHIONINEActive
Strength: 400 MG / 100 ML
Monograph: METHIONINE
PHENYLALANINEActive
Strength: 560 MG / 100 ML
Monograph: PHENYLALANINE
PROLINEActive
Strength: 680 MG / 100 ML
Monograph: PROLINE
SERINEActive
Strength: 500 MG / 100 ML
Monograph: SERINE
THREONINEActive
Strength: 420 MG / 100 ML
Monograph: THREONINE
TRYPTOPHANActive
Strength: 180 MG / 100 ML
Monograph: TRYPTOPHAN
TYROSINEActive
Strength: 40 MG / 100 ML
Monograph: TYROSINE
VALINEActive
Strength: 580 MG / 100 ML
Monograph: VALINE